The Trading Floor

[Arctec]

BIOTECH HOLDINGS SALES OF SUCANON SHOW QUARTERLY GROWTH
Vancouver, B.C., January 16, 2007 - Biotech Holdings (the "Company", CDNX: BIO.V; OTC BB: BIOHF) reports that sales for the quarter ended December 31, 2006 exceeded the combined sales of the first two quarters, ended September 30, 2006, by $55,692 or 73%. The sales during the quarter ended December 31, 2006, at $127,194, exceeds sales of $99,137 generated during the quarter ended December 31, 2005, and is the second-largest quarterly sales total recorded to date. The Company's interim financial statements, complete with Management Discussion and Analysis for the third quarter, ended December 31, 2006, will be issued in February, 2007, with filing to www.sedar.com, where all prior financial statements together with Management Discussion and Analysis are available.

In addition to the year-over-year sales increase, sales during the December 31, 2006 quarter itself increased each month, suggesting a trend of sales growth following the Company's resumption of advertising support for the product and the Company's managers taking over the marketing of Sucanon in Mexico in September, 2006.

For further information, contact Austin Rand at Biotech Holdings, 1 888 216 1111 (toll-free) 8 a.m. to 4 p.m. Pacific time. For background information on Biotech Holdings, or to receive news updates, see www.biotechltd.com.